P2RY1 and Alzheimer disease: Since CD39L1 modulates ATP metabolism and is particularly expressed in astrocytes (25), increased CD39L expression would reduce local ATP levels and thus dampen P2Y1-mediated astrocytic hyperactivity in CNS tissue with AD pathology, while its reduced expression, as suggested by the transcriptomic analyses, would have the opposite effect.